Recently Published - January 2013
BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
Eleni Lagadinou, Alexander Sach, Kevin Callahan, Randall M. Rossi, Sarah J. Neering, Mohammad Minjajuddin, John Ashton, Shanshan Pei, Valerie Grose, Kristen M. O’Dwyer, Jane Liesveld, Paul Brookes, Michael Becker, Craig Jordan.
Cell Stem Cell 17 January 2013
Front Genet. 2012;3:319. doi: 10.3389/fgene.2012.00319. Epub 2013 Jan 9.
Long-lived cancer-resistant rodents as new model species for cancer research.Azpurua J, Seluanov A. Department of Biology, University of Rochester
Cancer Chemother Pharmacol. 2013 Jan 13. [Epub ahead of print]
p75NTR: an enhancer of fenretinide toxicity in neuroblastoma.
Ganeshan V, Ashton J, Schor NF.
Center for Neural Development and Disease, University of Rochester Medical Center
Front Endocrinol (Lausanne). 2012;3:163. doi: 10.3389/fendo.2012.00163. Epub 2012 Dec 13.
Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).
Fung C, Vaughn DJ, Mitra N, Ciosek SL, Vardhanabhuti S, Nathanson KL, Kanetsky PA.
IEEE J Sel Top Quantum Electron. 2012 Jul;18(4):1367-1386. Epub 2011 Dec 2.
Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.
Choe R, Durduran T.
Department of Biomedical Engineering, University of Rochester